Key result
Multidisciplinary PLEX protocol is linked to ~27% fewer thrombotic complications alongside reduced bleeding.
Why the study?
Plasma Exchange (PLEX) is increasingly used for immune-mediated neurological diseases but data on associated thrombotic and haemorrhagic risks are limited.
Does implementing standardized guidelines for PLEX reduce thrombotic and haemorrhagic complications in patients with neurological diseases?
Observational (n=78)
Does implementing standardized guidelines for PLEX reduce thrombotic and haemorrhagic complications in patients with neurological diseases?
Answers are grounded in this paper and cite their sources.
Implementing standardized guidelines for plasma exchange reduces the risks of thrombotic and haemorrhagic complications.
Background Plasma Exchange (PLEX) is an increasingly used therapy for various immune-mediated neu- rological diseases. Treatment can be complicated by potentially life-threatening clots and bleeds but there is limited data available regarding these risks. Method and Intervention: A retrospective audit of the records of patients receiving PLEX in the NHNN for neurological disease from May 2019 – October 2020 was performed to identify thrombotic and haemor- rhagic complications. A multi-disciplinary PLEX working group was created to set guidelines for all aspects of the PLEX process including mode of vascular access, use of prophylactic heparin and fluid replace- ment. The service was subsequently re-audited. Results 46 patients were treated with plasma exchange between May 2019 and Oct 2020. 11% developed a thrombus requiring anticoagulation. 41% developed a haemorrhage, 42% of which required intervention. Following protocol change a review of 32 patients between November 2020 to October 2021 showed that there was a reduction of 27% in the incidence of thrombus and a 17% reduction in the incidence of haemorrhage. Conclusion PLEX is integral to the treatment of disabling and potentially fatal immune-mediated neuro-logical diseases. Careful consideration of all aspects of the PLEX process, reduces risks associated with treatment and improves patient safety.
No takes yet. Share an insight, caveat, or question.
Japzon et al. (2022) conducted an observational in Immune-mediated neurological diseases (n=78). Multi-disciplinary PLEX protocol (guidelines for vascular access, prophylactic heparin, and fluid replacement) vs. Standard care prior to protocol change was evaluated on Incidence of thrombus and haemorrhage (27% reduction in thrombus and 17% reduction in haemorrhage).
Synapse has enriched 10 related papers. Consider them for comparative context: